| Feb. 2, 2012 | 6:15–6:45 p.m. |  | The Interventional Management of Stroke (IMS) III Trial Joseph P. Broderick, MD, FAHA, University of Cincinnati, Cincinnati, Ohio |
|
 | The Combined Approach to Lysis Utilizing Eptifibatide and rt-PA in Acute Ischemic Stroke Enhanced Regimen (The CLEAR-ER Stroke Trial): An Ongoing Phase IIb Trial Arthur M. Pancioli, MD, FAHA, U Cincinnati Medical Center, Cincinnati, Ohio |
|
 | Mechanical Retrieval and Recanalization of Stroke Clots Using Embolectomy Chelsea Kidwell, MD, FAHA, Georgetown University, Washington D.C. |
|
 | The Field Administration of Stroke Therapy - Magnesium (FAST-MAG) Phase 3 Clinical Trial Jeffrey L. Saver, MD, FAHA, Geffen School of Medicine at UCLA, Los Angeles, Calif. |
|
| | Carotid Revascularization Endarterectomy versus Stenting Trial (CREST): Update On Long Term Follow-up (Up to 10 Years) Alice J. Sheffet, PhD, UMDNJ-New Jersey Medical Sch, Newark, N.J. |
|
|
| | Secondary Prevention of Small Subcortical Strokes Oscar Benavente, MD, University of British Columbia, Vancouver, BC, Canada |
|
 | MR WITNESS: A Phase IIa Safety Study of Intravenous Thrombolysis with Alteplase in MRI-Selected Patients Ona Wu, PhD, Massachusetts General Hospital, Boston, Mass. |
|
 | A Phase II RCT of Stroke Navigators to Improve Compliance with Secondary Stroke Prevention: PROTECT DC Alexander W. Dromerick, MD, National Rehabilitation Hospital, Washington, D.C. |
|
 | STOP-IT Study Matthew Flaherty, MD, on Behalf of STOP-IT Study Investigators, University of Cincinnati, Cincinnati, Ohio |
|
 | Thrombolysis in Pediatric Stroke (TIPS) Catherine Amlie-Lefond, MD, Seattle Children's Hospital, Seattle, Wash. |
|
|
|
|
